Term
|
Definition
- causative agent: N. gonorrhea
- highest incidence in developing countries (lowest in Europe)
- higest in 15-19 yr olds
- more cases reported in men
|
|
|
Term
|
Definition
- perinatal
- sexual contact
- F to M: 20% per contact (60-80% after 4 or more exposures
- M to F: 50% per contact
|
|
|
Term
gonorrhea: clinical manifestations |
|
Definition
- incubation: 2-10 days
- men: purulent discharge, dysuria, urethritis, or may be asymptomatic
- women: vaginal discharge, dysuria, cervicitis, 90% may be asymptomatic
- anorectal- proctitis, purulent discharge
- pharyngeal disease (may be asymptomatic)
- conjunctivitis of newborn- purulent exudate within week of delivery
|
|
|
Term
|
Definition
- 10-20% get ascending infection: PID, endometritis, salpingitis, tubo-ovarian abscess
- bartholinitis
- acute epididymitis
- disseminated disease with arthritis-dermatitis syndrome
- migratroy polyarthritis/tenosynovitis and dermititis (hemorrhagic papules/pustules)
- synovial fluid reveal septic arthritis, but only 50% have blood or joint fluid that are positive
|
|
|
Term
|
Definition
- gram stain: specific for genital lesions
- culture with selective media (Thayer Martin)
- nucleic acid probes
|
|
|
Term
|
Definition
- widespread penicillin R
- coinfection with chlamydia in some pts
- most cases resolve spontaneously
- uncomplicated infection
- single dose cephalosporin, quinolone, otherwise multiple doses
|
|
|
Term
|
Definition
- substantially less transmissible than gonorrhea
- transmitted by sexual contact and perinatally
- many men and most women are asymptomatic
- high incidence of co infection with N. gonorrhea
causative agent: Chlamydia trachomatis |
|
|
Term
chlamydia: clinical manifestation |
|
Definition
- urethritis: causes many NGU cases
- in men: dysuria, urethral dischage (less purulent), epididymitis/prostatitis, proctitis, rectal strictures, fistulae, abscesses
- in women: cervicitis, urethritis, mild dischange, bartholinitis, endometritis, salpingitis, PID
- reactive arthritis- immune mediated and aseptic (part of Reiter's syndreom)
- infants: conjunctivitis, pneumonia
- in developing world, lymphogranuloma venereum
|
|
|
Term
chylamydia: lymphogranuloma venereum (epidemiology, primary and secondary lesions) |
|
Definition
- endemic- SE Asia, Africa, Carribean
- primary lesion- asymptomatic papule or ulcer, heals rapidly, occurs 3-30 days post infection
- secondary (days to weeks)- adenopathy which progresses to an inflammatory mass and drains
|
|
|
Term
|
Definition
- stained smears (insenstive EXCEPT in conjunctivitis): intracytoplasmic inclusions
- serology
- culture (labor intensitve)
- nucleic acid amplification tests
|
|
|
Term
|
Definition
|
|
Term
Trichomonas vaginalis (epidemiology) |
|
Definition
- protozoan parasite
- self limited in a good amount of men
- recovered from the majority of female partners of infected men and a good amount of male partners of infected women
|
|
|
Term
Trichomoniasis: clinical features |
|
Definition
- symptoms often begin or exacerbate during menstration
- vaginal discharge (yellow, thick), vulvovaginal irritation, dyspareunia, urethritis, cervicitis
- complications
- premature rupture of membranes
- low birth weight
- men usually asymptomatic and some women are asymptomatic as well
|
|
|
Term
trichomoniasis: dx and tx |
|
Definition
- dx
- wet prep: 80% sensitive and highly specific
- culture in liquid medium (Diamond's medium)
- rapid Ag test
- tx- oral metronidazole
|
|
|
Term
chancroid: causative agent, epidemiology |
|
Definition
- epidemiology
- major outbreaks recently in US
- only 10% reported in women (inapparent carrier state)
- causative agent: Haemophilis ducreyi
|
|
|
Term
chancroid: clinical manifestations |
|
Definition
- incubation period 1 day to sever weeks
- generally confined to genitalia
- initially begins as tender papule with surrounding erythema, becomes pustular and forms painful undermined ulcer (ulcers can be single or multiple)
- tender regional adenopathy (cases which can suppurate and form draining sinuses)
- superinfection can occur
|
|
|
Term
|
Definition
- dx
- culture, gram stain
- gram negative rods in characteristic "school of fish: pattern (not very sensitive)
- PCR
- tx
- single dose azithro
- single dose ceftriaxone
- ciprofoxacin
|
|
|
Term
bacterial vaginosis (epidemiology) |
|
Definition
- most common cause of vaginitis
- caused by replacement of normal flora with anaerobes (ex: Gardnerella vaginalis)
- found in 2/3 of women without signs and symptoms of infection
- male sexual partners are usually colonized by asymptomatic
|
|
|
Term
bacterial vaginosis: clinical manfestations, dx, tx |
|
Definition
- clinical manifstation- increased vaginal discharge with a "fishy" odor
- dx
- gram stain of vaginal fluid reveals clue cells
- epithelial cells covered with small coccobacilliary forms
- culture less useful
- IFA
DNA probe- vaginitis panel- test for Gardnarella, Candida, Trichomonas
- tx- metronidazole
|
|
|
Term
syphilis: epidemiology, transmission |
|
Definition
- causative agent- Treponema pallidum
- epidemiology and transmission
- highly infectious
- transmitted by venereal contact, transplacentally, transfusion, needle stick, most infectious early in desease
- majority of cases 15-30 age range
|
|
|
Term
|
Definition
- penetrates skin and spread through blood and lymphatics
- any organ can be invaded, including CNS
- it can cause obliterative endarteritis or large granulomatous lesions (gummas)
|
|
|
Term
syphilis: clinical manifestation in primary stage |
|
Definition
- chancre form at site of inoculation
- initially painless papule, erodes with rasied borders
- heals in 3-6 wks
- can be multiple, atypical, or absent
- can be on cervix, mouth, perianal area
- accompanied with adenopathy
|
|
|
Term
syphilis: clinical manifestations of secondary phase |
|
Definition
- 2-8 wks after appearance of chancre
- disseminated diases
- maculopapular rash can involve any surface of body, presence on palms and soles is highly suggestive
- papules can coalesce to form gray-white highly infectious plaques called condylomata lata
- highly infectious patches teeming with spirochetes can form on mucous membranes
- constitutional symptoms common: enlargement of epitrochlear nodes highly suggestive
- CNS involvement in some cases: CN involvement, meningitis
- glomerulonephritis, hepatitis, uveitis, proctitis, synovitis
|
|
|
Term
syphilis: clinical manifestation of latenet phase |
|
Definition
no clinical manifestations with positive serology |
|
|
Term
syphilis: clinical manifestations of tertiary phase |
|
Definition
- progressive inflammatory disease can affect any organ
- neurosyphilis
- no symptoms in some cases
- dx- abnormalities of CSF if tested
- elevatred CSF WBC
- elevated protein
- low glucose
- positive VDRL
- CV syphilis- endarteritis cause aortitis and aneurysm formation
- late benign syphilis (gummas)- granulomatous lesions can be seen in any organ
- syphilitic otitis- asymmetric deafness, tinnitis
- CN palsies- VII, VIII most common
|
|
|
Term
syphilis: neurosyphilis symptomatic disease |
|
Definition
- meningovascular (inflammatory) endarteritis oblinterans, involving small bv's, leading to multiple small infarcts, progressive neurological deficits, seizures
- parenchematous (degenerative) leading to neruologic symptoms and psyc disease
|
|
|
Term
syphilis: clinical manifestation of tertiary disease parenchymatous disease |
|
Definition
- PARESIS (constellation of psyc and neuro symptoms)
- personality
- affect
- refelxes
- eyes (Argyll Robinson pupil, optic atrophy)
- sensorium
- intellect
- speech
- tabes dorsalis- demyeliniation of DRG
- ataxic gait
- foot slap
- paresthesias
- incontinence
- impotence
- Charcot joints as resulte of sensory loss
|
|
|
Term
|
Definition
- darkfield examination
- serologic tests- nonspecific, nontreponemal reaginic tests: VDRL and RPR
- used to screen, most reliable for secondary syphilis, false positives can occur
- become positive 3-6 weeks after inoculation
- titers decrease with tx, length of time for the test to become negative depnds on severity of illness and interval between contact and therapy initiation
- specific treponomal tests: FTA-Ab and MHA-TP
- remain positive for live despite tx
- less incidence of false positive
|
|
|
Term
|
Definition
- positive VDRL is proof of CNS involvement
- negative VDRL does not rule out neurosyphilis (only 30-40% with neurosyphilis will have positive VDRL)
- RPR negative in 25% of pts with late syphilis
- dx often made in suspected individual with positive RPR and or FTA and CSF abnormalities
|
|
|
Term
|
Definition
- tx best studied with penecilin
- early disease- IM injections (one shot) but if recurrent or neurosyphilis, give them 3 shots
- neurosyphilis is IV penicillin
- alternatives: doxycycline, ceftriaxone
|
|
|
Term
HPV- anogential warts aka condylomata acuminata: epidemiology |
|
Definition
- recent dramatic increase in prevalance of disease
- 2/3 of sexual contacts develop disease
- in kdis, respiratory papillamatosis
- infection often asymptomatic
|
|
|
Term
HPV associated with malignancies |
|
Definition
- 6 and 11 associated with external genital warts and minimal risk of malignancy
- other HPV's associated with flat warts and increase risk of carcinoma of cervic, vagina, vulva, anus, and penis
|
|
|
Term
HPV: clinical manifestations |
|
Definition
- fresh to gray colored papules either sessile or pedunculated, they may merge into plaques
- in men: usually on penile shaft, urethra may be involved
- in women, usually posterior interoitus, labia
- flat condylomas on cervix, vagina
- perianal warts
|
|
|
Term
|
Definition
- application of acetic acid solution
- colposcopy
- biopsy (characteristic histopathology)
- Pap smear to rule out dsyplasia
- HPV DNA detection
|
|
|
Term
|
Definition
- no tx is predictably curative and relapses are common
- cryotherapy
- laser ablasion
- podophyllin
- interlesional IFN
- imiquimod cream
- 5-fluorouracil
|
|
|
Term
|
Definition
- vaccine approaved recently
- protect against types 6,11,16,18 (protect against a lot of cancers and most warts)
- ideally administered before individual becomes sexually active
- close to 100% efficacy
|
|
|